Deal of the Day — limited-time pharmacy picks!
Acriptega 50mg Tablet

Acriptega 50mg Tablet

Prescription requiredRx Required

Salt Composition: Dolutegravir lamivudine tenoflovir

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

30 tablet

About The Product

HIV

Acriptega 50mg Tablet is an antiviral medicine with the combination of Dolutegravir (50mg), Lamivudine (300mg) and Tenofovir disoproxil fumarate (300mg) as an active ingredients. It is prescribed to manage human immunodeficiency virus (HIV) infection in both adults and children weighing at least 40 kg.

It can be given for patients who are responding well to treatment and have no history of treatment failure, as well as for those beginning antiretroviral medication or to replace an existing treatment. It should be taken with food at the same time each day to get effective results. Don't take more than the recommended dose.

Reference

Orrell, C., Hagins, D. P., Belonosova, E., Porteiro, N., Walmsley, S., Falcó, V., ... & Van Dam, C. N. (2017). Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study. The Lancet HIV, 4(12), e536-e546 - https://pubmed.ncbi.nlm.nih.gov/28729158/

Venter, W. D., Sokhela, S., Simmons, B., Moorhouse, M., Fairlie, L., Mashabane, N., ... & Hill, A. (2020). Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. The lancet HIV, 7(10), e666-e676 - https://pubmed.ncbi.nlm.nih.gov/33010240/

Zamora, F. J., Dowers, E., Yasin, F., & Ogbuagu, O. (2019). Dolutegravir and lamivudine combination for the treatment of HIV-1 infection. HIV/AIDS-Research and Palliative Care, 255-263 - https://pubmed.ncbi.nlm.nih.gov/31749636/

Scott, L. J. (2020). Dolutegravir/lamivudine single‑tablet regimen: a review in HIV‑1 infection. Drugs, 80(1), 61-72 - https://pubmed.ncbi.nlm.nih.gov/31865558/

Cahn, P., Madero, J. S., Arribas, J. R., Antinori, A., Ortiz, R., Clarke, A. E., ... & Perea, R. T. (2019). Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. The Lancet, 393(10167), 143-155 - https://pmc.ncbi.nlm.nih.gov/articles/PMC8725510/



Side Effects

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.
Some common side effects of Acriptega 50mg Tablet include:

  • Headache
  • Fatigue
  • Stomach Pain
  • Increased Lipase Enzyme In Blood
  • Loose And Watery Stools
  • Dizziness
  • Nausea

Dosage and Administration

  • The dosage and treatment duration of the Acriptega 50mg Tablet are decided by the doctor according overall patient's health.
  • This tablet should be taken with or without food, but at the fix time every day to get effective results.
  • Don't miss a dose or overdose on the medicine.


Safety Advice

Alcohol: Avoid the consumption of alcohol while taking Acriptega 50mg Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms. Pregnancy: Do not take Acriptega 50mg Tablet without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.

Breastfeeding: Breastfeeding women should discuss the potential risks and benefits of the Acriptega 50mg Tablet with their healthcare provider before starting treatment. Driving: Acriptega 50mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive.

So it's better to avoid driving. Kidney: Share your medical history with the doctor before starting the Acriptega 50mg Tablet.

Do not take it without consulting a doctor if you have any kidney related issue. Liver: Share your medical history with the doctor before starting the Acriptega 50mg Tablet.

Do not take it without consulting a doctor if you have any liver related issue.

Missed Doses

  • It is advisable not to miss any dose.
  • In case you miss a dose of Acriptega 50mg tablets consult your doctor immediately.

FAQs

Acriptega 50mg Tablet is an antiviral medicine that works by blocking the replication of the virus to reduce its levels in the body.

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026